JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.54B |
| 2 |
NVIDIA
NVDA
|
+$5.22B |
| 3 |
Apple
AAPL
|
+$3.2B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$2.51B |
| 5 |
Walt Disney
DIS
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.6B |
| 2 |
UnitedHealth
UNH
|
+$2.41B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.15B |
| 4 |
Linde
LIN
|
+$1.93B |
| 5 |
Union Pacific
UNP
|
+$1.87B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.6% |
| 2 | Financials | 9.92% |
| 3 | Consumer Discretionary | 9.63% |
| 4 | Communication Services | 7.24% |
| 5 | Healthcare | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Toll Brothers
TOL
$14B
| $49.8M | ﹤0.01% |
436,267
-232,332
| -35% | -$24.1M |
|
1327
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.3B
| $49.8M | ﹤0.01% |
594,448
-70,697
| -11% | -$5.61M |
|
1328
Lumen
LUMN
$6.85B
| $49.6M | ﹤0.01% |
11,320,094
+6,204,619
| +121% | +$24M |
|
1329
Sabra Healthcare REIT
SBRA
$5.28B
| $49.5M | ﹤0.01% |
2,685,412
-1,301,649
| -33% | -$23.1M |
|
1330
Rhythm Pharmaceuticals
RYTM
$7.95B
| $49.5M | ﹤0.01% |
783,559
+639,919
| +446% | +$39.2M |
|
1331
iShares MSCI USA Equal Weighted ETF
EUSA
$1.93B
| $49.4M | ﹤0.01% |
498,781
+469,888
| +1,626% | +$44.1M |
|
|
ABLD
1332
Abacus FCF Real Assets Leaders ETF
ABLD
$97.1M
| $49.3M | ﹤0.01% |
1,728,558
+131,441
| +8% | +$3.63M |
|
1333
Vanguard Russell 1000 Value ETF
VONV
$22B
| $49.2M | ﹤0.01% |
577,227
+59,776
| +12% | +$4.86M |
|
1334
Zurn Elkay Water Solutions
ZWS
$8.47B
| $49.2M | ﹤0.01% |
1,344,264
-176,356
| -12% | -$6.07M |
|
1335
APi Group
APG
$18.3B
| $49M | ﹤0.01% |
1,439,111
+301,806
| +27% | +$8.64M |
|
1336
Apogee Therapeutics
APGE
$10.2B
| $48.9M | ﹤0.01% |
1,125,570
+162,939
| +17% | +$6.2M |
|
1337
Fidelity High Dividend ETF
FDVV
$10.4B
| $48.7M | ﹤0.01% |
935,539
-27,172
| -3% | -$1.34M |
|
1338
Integer Holdings
ITGR
$4.25B
| $48.6M | ﹤0.01% |
395,296
+295,364
| +296% | +$35.3M |
|
1339
CALL
Merck
MRK
$323B
| $48.4M | ﹤0.01% |
611,900
+325,000
| +113% | +$25.8M |
|
1340
CALL
Goldman Sachs
GS
$301B
| $48.4M | ﹤0.01% |
68,400
-55,500
| -45% | -$32.2M |
|
1341
Molina Healthcare
MOH
$10.4B
| $48.4M | ﹤0.01% |
162,423
-27,051
| -14% | -$8.49M |
|
1342
Antero Resources
AR
$11.4B
| $48.4M | ﹤0.01% |
1,200,529
+258,851
| +27% | +$9.8M |
|
1343
Annaly Capital Management
NLY
$17.3B
| $48.3M | ﹤0.01% |
2,567,695
+44,526
| +2% | +$847K |
|
1344
FirstService
FSV
$6.27B
| $48.2M | ﹤0.01% |
275,849
+5,339
| +2% | +$925K |
|
1345
West Pharmaceutical
WST
$24.8B
| $48.1M | ﹤0.01% |
220,044
-435,132
| -66% | -$93M |
|
1346
InterDigital
IDCC
$8.99B
| $48.1M | ﹤0.01% |
214,647
+91,138
| +74% | +$19.3M |
|
1347
STAG Industrial
STAG
$7.09B
| $48.1M | ﹤0.01% |
1,324,872
+5,573
| +0.4% | +$193K |
|
1348
Stride
LRN
$3.33B
| $47.9M | ﹤0.01% |
330,008
+54,994
| +20% | +$7.95M |
|
1349
Pinnacle West Capital
PNW
$12B
| $47.9M | ﹤0.01% |
535,435
-64,154
| -11% | -$5.87M |
|
1350
CALL
PayPal
PYPL
$50.5B
| $47.7M | ﹤0.01% |
641,800
-104,000
| -14% | -$7.12M |
|
Similar funds
JP Morgan Chase's Q2 2025 Portfolio in Review
As of Q2 2025, JP Morgan Chase held 7,888 positions worth $1.53T, up 12% from $1.37T the previous quarter. Its ten largest holdings account for 25% of the portfolio.
JP Morgan Chase's Q2 2025 filing shows 634 new, 2,516 increased, 3,216 reduced and 855 closed positions. Its largest new stake was JPMorgan Mortgage-Backed Securities ETF: 10,818,420 shares worth $543M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.6B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q2 2025 buy was JPMorgan Mortgage-Backed Securities ETF: 10,818,420 shares worth $543M.
- JP Morgan Chase added most to Microsoft in Q2 2025, an estimated $6.54B increase.
- JP Morgan Chase's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.6B.
- JP Morgan Chase fully exited Discover Financial Services in Q2 2025, selling an estimated $370M.
- JP Morgan Chase's ten largest holdings make up 25% of its $1.53T portfolio in Q2 2025.
- JP Morgan Chase opened 634 new positions and closed 855 in Q2 2025.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $1.53T.
Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.